The US Department of Health and Human Services (HHS) has denied reports that it plans to cut billions of dollars in funding for anti-HIV programs, causing shares of Gilead Sciences to drop by over 3% on Wednesday.
Source: https://endpts.com/gilead-stock-slips-as-hhs-denies-reports-of-hiv-funding-cuts